MJGT_F_H likely restores pancreatic β-cell insulin secretion capacity by elevating serum GLP-1 levels in T2DM rats, thereby inducing β-cell proliferation and reducing apoptosis. Here, GLP1R is linked to type 2 diabetes mellitus.